Genitourinary adverse effects

1 paper

Human trial1

Latest

1 in 12 months

PLOS One7 Oct

Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study

Non-randomised trial in 7 peopleDapagliflozin